Dawes Fretzin Dermatology Group, LLC is a clinical research site located in Indianapolis, Indiana, United States 46256.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Dawes Fretzin Dermatology Group, LLC has participated in 10 clinical trials with 1 currently active.
Therapeutic areas: Alopecia Areata, Systemic Lupus Erythematosus, Arthritis, Rheumatoid.
Sponsors: Pfizer, EMD Serono Research & Development Institute, Inc., Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Dawes Fretzin Dermatology Group, LLC has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dawes Fretzin Dermatology Group, LLC has 10 clinical trials on record, with 1 currently active. Their work covers Alopecia Areata, Systemic Lupus Erythematosus, Arthritis, Rheumatoid.
Yes — Dawes Fretzin Dermatology Group, LLC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.